09:55 AM EST - Titan Medical Inc. : confirmed that the Company's management is unaware of any material change in the Company's operations that would account for the recent increase in market activity. Titan is developing a Single Port Orifice Robotic Technology (SPORT™) Surgical System for minimally invasive surgery. Titan recently announced that it had started tissue testing which has been highly successful in assessing and measuring the functionality of the SPORT™ Surgical System. Tissue testing constitutes the first major milestone on Titan's pathway to commercialization which is expected in 2015. Titan Medical Inc.
shares V.TMD are trading up $0.01 at $0.81.
